vs
Astrana Health, Inc.（ASTH）与朗美通（LITE）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是朗美通的1.4倍（$950.5M vs $665.5M），朗美通净利率更高（11.8% vs 0.7%，领先11.1%），朗美通同比增速更快（65.5% vs 42.9%），朗美通自由现金流更多（$43.1M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 34.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
朗美通控股（Lumentum Holdings Inc.）是全球知名光电产品供应商，前身为美国捷迪讯（JDSU）旗下光电器件及激光业务板块，2015年8月随捷迪讯分拆独立运营，总部位于美国加利福尼亚州米尔皮塔斯，主营光通信网络设备、激光器、定制光学解决方案等多元产品。
ASTH vs LITE — 直观对比
营收规模更大
ASTH
是对方的1.4倍
$665.5M
营收增速更快
LITE
高出22.6%
42.9%
净利率更高
LITE
高出11.1%
0.7%
自由现金流更多
LITE
多$49.0M
$-6.0M
两年增速更快
ASTH
近两年复合增速
34.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $665.5M |
| 净利润 | $6.6M | $78.2M |
| 毛利率 | — | 36.1% |
| 营业利润率 | 1.9% | 9.7% |
| 净利率 | 0.7% | 11.8% |
| 营收同比 | 42.9% | 65.5% |
| 净利润同比 | 184.4% | 228.4% |
| 每股收益（稀释后） | $0.12 | $0.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHLITE
| Q4 25 | $950.5M | $665.5M | ||
| Q3 25 | $956.0M | $533.8M | ||
| Q2 25 | $654.8M | $480.7M | ||
| Q1 25 | $620.4M | $425.2M | ||
| Q4 24 | $665.2M | $402.2M | ||
| Q3 24 | $478.7M | $336.9M | ||
| Q2 24 | $486.3M | $308.3M | ||
| Q1 24 | $404.4M | $366.5M |
净利润ASTHLITE
| Q4 25 | $6.6M | $78.2M | ||
| Q3 25 | $373.0K | $4.2M | ||
| Q2 25 | $9.4M | $213.3M | ||
| Q1 25 | $6.7M | $-44.1M | ||
| Q4 24 | $-7.8M | $-60.9M | ||
| Q3 24 | $16.1M | $-82.4M | ||
| Q2 24 | $19.2M | $-252.5M | ||
| Q1 24 | $14.8M | $-127.0M |
毛利率ASTHLITE
| Q4 25 | — | 36.1% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 33.3% | ||
| Q1 25 | — | 28.8% | ||
| Q4 24 | — | 24.8% | ||
| Q3 24 | — | 23.1% | ||
| Q2 24 | — | 16.6% | ||
| Q1 24 | — | 16.2% |
营业利润率ASTHLITE
| Q4 25 | 1.9% | 9.7% | ||
| Q3 25 | 2.0% | 1.3% | ||
| Q2 25 | 3.1% | -1.7% | ||
| Q1 25 | 3.3% | -8.9% | ||
| Q4 24 | 0.1% | -12.8% | ||
| Q3 24 | 5.9% | -24.5% | ||
| Q2 24 | 6.2% | -43.3% | ||
| Q1 24 | 7.5% | -31.3% |
净利率ASTHLITE
| Q4 25 | 0.7% | 11.8% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 1.4% | 44.4% | ||
| Q1 25 | 1.1% | -10.4% | ||
| Q4 24 | -1.2% | -15.1% | ||
| Q3 24 | 3.4% | -24.5% | ||
| Q2 24 | 3.9% | -81.9% | ||
| Q1 24 | 3.7% | -34.7% |
每股收益（稀释后）ASTHLITE
| Q4 25 | $0.12 | $0.89 | ||
| Q3 25 | $0.01 | $0.05 | ||
| Q2 25 | $0.19 | $3.10 | ||
| Q1 25 | $0.14 | $-0.64 | ||
| Q4 24 | $-0.14 | $-0.88 | ||
| Q3 24 | $0.33 | $-1.21 | ||
| Q2 24 | $0.40 | $-3.75 | ||
| Q1 24 | $0.31 | $-1.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $846.6M |
| 总资产 | $2.2B | $4.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHLITE
| Q4 25 | $429.5M | $1.2B | ||
| Q3 25 | $463.4M | $1.1B | ||
| Q2 25 | $342.1M | $877.1M | ||
| Q1 25 | $260.9M | $866.7M | ||
| Q4 24 | $290.8M | $896.7M | ||
| Q3 24 | $350.3M | $916.1M | ||
| Q2 24 | $327.7M | $887.0M | ||
| Q1 24 | $337.3M | $870.9M |
股东权益ASTHLITE
| Q4 25 | $779.3M | $846.6M | ||
| Q3 25 | $775.5M | $780.8M | ||
| Q2 25 | $765.5M | $1.1B | ||
| Q1 25 | $745.4M | $879.5M | ||
| Q4 24 | $712.7M | $872.3M | ||
| Q3 24 | $704.6M | $895.9M | ||
| Q2 24 | $678.9M | $957.3M | ||
| Q1 24 | $653.5M | $1.2B |
总资产ASTHLITE
| Q4 25 | $2.2B | $4.8B | ||
| Q3 25 | $2.2B | $4.6B | ||
| Q2 25 | $1.4B | $4.2B | ||
| Q1 25 | $1.3B | $4.0B | ||
| Q4 24 | $1.4B | $4.0B | ||
| Q3 24 | $1.3B | $4.0B | ||
| Q2 24 | $1.3B | $3.9B | ||
| Q1 24 | $1.2B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $126.7M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $43.1M |
| 自由现金流率自由现金流/营收 | -0.6% | 6.5% |
| 资本支出强度资本支出/营收 | 0.3% | 12.6% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.62× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $-29.5M |
8季度趋势，按日历期对齐
经营现金流ASTHLITE
| Q4 25 | $-2.9M | $126.7M | ||
| Q3 25 | $10.0M | $57.9M | ||
| Q2 25 | $90.9M | $64.0M | ||
| Q1 25 | $16.6M | $-1.6M | ||
| Q4 24 | $-10.9M | $24.3M | ||
| Q3 24 | $34.0M | $39.6M | ||
| Q2 24 | $23.2M | $35.5M | ||
| Q1 24 | $6.0M | $-7.0M |
自由现金流ASTHLITE
| Q4 25 | $-6.0M | $43.1M | ||
| Q3 25 | $7.4M | $-18.3M | ||
| Q2 25 | $89.5M | $10.1M | ||
| Q1 25 | $13.6M | $-64.4M | ||
| Q4 24 | $-13.5M | $-15.9M | ||
| Q3 24 | $31.7M | $-34.5M | ||
| Q2 24 | $20.4M | $10.9M | ||
| Q1 24 | $5.6M | $-26.6M |
自由现金流率ASTHLITE
| Q4 25 | -0.6% | 6.5% | ||
| Q3 25 | 0.8% | -3.4% | ||
| Q2 25 | 13.7% | 2.1% | ||
| Q1 25 | 2.2% | -15.1% | ||
| Q4 24 | -2.0% | -4.0% | ||
| Q3 24 | 6.6% | -10.2% | ||
| Q2 24 | 4.2% | 3.5% | ||
| Q1 24 | 1.4% | -7.3% |
资本支出强度ASTHLITE
| Q4 25 | 0.3% | 12.6% | ||
| Q3 25 | 0.3% | 14.3% | ||
| Q2 25 | 0.2% | 11.2% | ||
| Q1 25 | 0.5% | 14.8% | ||
| Q4 24 | 0.4% | 10.0% | ||
| Q3 24 | 0.5% | 22.0% | ||
| Q2 24 | 0.6% | 8.0% | ||
| Q1 24 | 0.1% | 5.3% |
现金转化率ASTHLITE
| Q4 25 | -0.44× | 1.62× | ||
| Q3 25 | 26.69× | 13.79× | ||
| Q2 25 | 9.65× | 0.30× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
LITE
| Components | $443.7M | 67% |
| Systems | $221.8M | 33% |
